Amgen olpasiran may fill critical treatment gap in lowering Lp(a): GlobalData
This study showed that patients taking 75mg of Olpasiran previously every 12 weeks presented a 40–50% reduction in LP(a)
This study showed that patients taking 75mg of Olpasiran previously every 12 weeks presented a 40–50% reduction in LP(a)
The cognitively operated system is a mother patent invention, first launched in India
This approval has come from the company's finished dosage form manufacturing facility
Robots make it to the healthcare conference panel, reflecting the future potential of technology
Sets price band at ?695 to ?735 per Equity Share
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
Mankind Pharma's initiative aims to ensure universal access to medicines of international calibre
The three-week travel campaign is aimed at spreading awareness about infertility and making Karnataka infertility-free
Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
Subscribe To Our Newsletter & Stay Updated